Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Refractory Solid Tumor · Hepatocellular Carcinoma · Malignant Solid Tumor · Pediatric Cancer · Pediatric Solid Tumor · Fibrolamellar Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Methodist Le Bonheur Healthcare, Germantown, Tennessee, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Jessica Gartrell, MD)
Study leads
Jessica Gartrell, MD
Principal Investigator
St. Jude Children's Research Hospital